Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2025-12-24 @ 7:59 PM
NCT ID:
NCT05570604
Eligibility Criteria:
Inclusion Criteria:
1. Female gender
2. ≥ 21 years old at the time of informed consent
3. Ability to provide written informed consent and HIPAA authorization
4. First diagnosis of non-metastatic breast cancer.
5. Self-reported cognitive impairment
6. Subjects seeking treatment though not currently being treated or with prior treatment history for cognitive impairment.
7. ≥ 1 year post-treatment including surgery, radiation, and/or chemotherapy
8. Ability to understand, speak, read, and write English
Exclusion Criteria:
1. Comorbidities that would sufficiently impair performance or inhibit cognitive training such as: history of stroke, encephalitis, traumatic brain injury, brain surgery, dementia, or Alzheimers disease.
2. Cranial radiation or intrathecal therapy.
3. Current active major depression or substance abuse or history of bipolar disorder psychosis, schizophrenia, or learning disability.
4. History of current or other cancer except for basal cell skin cancer.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
21 Years
Study:
NCT05570604
Study Brief:
Protocol Section:
NCT05570604